Why is Morepen Labs. falling/rising?

As of 25-Aug, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 48.24, reflecting a decrease of 0.79 or 1.61%. The stock has underperformed its sector by 2.02% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of 3.02% during this period. Over the past month, the stock has seen a significant drop of 19.52%, and its year-to-date performance shows a staggering decline of 38.39%. Despite having a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.3, the company's profits have fallen by 21.3%, contributing to its negative performance. Additionally, the company has reported poor financial results in recent quarters, with net sales dropping by 8.72%, leading to a lack of confidence among investors, as evidenced by the minimal domestic mutual fund holdings.
In the broader market context, Morepen Laboratories Ltd's short-term performance has lagged behind the benchmark, with a 1-week return of 0.29% compared to the Sensex's 0.45%. The stock's long-term outlook is also concerning, as it has underperformed the BSE500 over the past three years, one year, and three months. The overall market sentiment appears to be cautious, particularly given the company's recent negative results and declining investor participation, which has seen a 43.69% drop in delivery volume against the 5-day average. This combination of poor financial performance, lack of investor confidence, and underperformance relative to the benchmark suggests a challenging environment for Morepen Laboratories Ltd.